For a series that's supposed to be ending this year (or at least ceasing production for the time being) if you've actually watched this season, you'd think that it still had many more years in it's future. Sure, if it ended after seasons 13-16, I might disagree. However, the show seems to have just hit it's good spot again.
With the old EP going off to do http://www.listal.com/tv/aaron-stone">Aaron Stone, we were treated to a new guy in charge -- who was later replaced mid-season with the man who had been with the show for the first nine seasons, who produced (arguably) the fandom's favorite seasons.
We start off the season with a race to Corinth City, where we meet our core three Rangers: Scott, Flynn and Summer. They're joined by the eccentric Ziggy and brooding, bad boy Dillon. Along with their mentor, Dr. K and military head, Colonel Truman [with his (bumbling) sidekick, Corporal Hicks] we've got our good guy team that's ready to fight Venjix and his army of robotic soldiers.
This is the first season in awhile that's successfully used a multi-cultural cast. We've got an African-American Red, Scottish Blue, a Yellow from a rich family, an eccentric, mob failure as Green, a bad boy robot as Black, a child genius as mentor and Asian twins as Gold and Silver. This is probably the most diverse cast since moving the show to New Zealand -- if only because Operation Overdrive failed to realize how diverse their cast was.
With this season moving into Mighty Morphin Reversioned, I'm a little disappointed. R.P.M. shows that the show has still got it, so reruns in 2010 aren't as exciting as how much they want us to be excited. Again, if the reversioned reruns followed seasons 13-16, I might think differently. But the show has just hit it's groove again. I love Mighty Morphin as much as the next 90s kid (possibly more), but I can't help but think of what a Judd Lynn adaptation of http://www.listal.com/tv/samurai-sentai-shinkenja">Shinkenger might look like -- and I'm not just saying that 'cause the suits look awesome either.